SGI Stock Analysis: Somnigroup International | NYSE
Furnishings, Fixtures & Appliances | NYSE, USA | Market Cap: 14.455m USD | 12M Return: -33.5% | US88023U1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 203M
EPS Trend: 95.4%
Qual. Beats: 0
Rev. Trend: 86.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Somnigroup International Inc. (NYSE: SGI) designs, manufactures, distributes, and retails bedding products in the United States and internationally. Its product line includes mattresses, foundations, adjustable bases, pillows, and related accessories sold under owned brands such as Tempur-Pedic, Sealy, Stearns & Foster, and Sleepys.
The company operates a vertically integrated model, combining manufacturing with a sizable retail footprint that includes Mattress Firm, Dreams, Tempur-Pedic retail stores, and SOVA, and it licenses its Sealy, Tempur, and Stearns & Foster brands and technology to third-party manufacturers. Products are sold through company-owned stores, e-commerce, and call centers, as well as third-party retailers serving distribution, hospitality, and healthcare customers.
Founded in 1846 and headquartered in Dallas, Texas, the company was previously known as Tempur Sealy International before adopting the Somnigroup International name in February 2025. The bedding industry is a mature consumer-discretionary category driven primarily by replacement-cycle demand tied to housing turnover and new household formation, with growth increasingly influenced by premium and adjustable-base product mix.
- Mattress Firm store expansion drives direct retail revenue growth
- Tempur-Pedic and Sealy premium brand pricing supports margin expansion
- Housing slowdown and consumer durables demand weakness pressures bedding sales
- Raw material and commodity cost fluctuations compress mattress manufacturing margins
- Competition from online DTC mattress brands and private label intensifies market share risk
- Capital allocation through dividends and debt reduction signals shareholder return focus
| Net Income: 519.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.56 > 1.0 |
| NWC/Revenue: 7.30% < 20% (prev -6.34%; Δ 13.64% < -1%) |
| CFO/TA 0.06 > 3% & CFO 931.3m > Net Income 519.4m |
| Net Debt (7.36b) to EBITDA (1.21b): 6.06 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (220.2m) vs 12m ago 3.62% < -2% |
| Gross Margin: 43.73% > 18% (prev 42.31%; Δ 1.41% > 0.5%) |
| Asset Turnover: 58.85% > 50% (prev 59.79%; Δ -0.94% > 0%) |
| Interest Coverage Ratio: 3.90 > 6 (EBIT TTM 944.6m / Interest Expense TTM 242.5m) |
| A: 0.04 (Total Current Assets 3.03b - Total Current Liabilities 2.46b) / Total Assets 15.3b |
| B: 0.27 (Retained Earnings 4.10b / Total Assets 15.3b) |
| C: 0.07 (EBIT TTM 944.6m / Avg Total Assets 13.3b) |
| D: 0.44 (Book Value of Equity 4.63b / Total Liabilities 10.6b) |
| Altman-Z'' = 2.06 = BBB |
| DSRI: 1.99 (Receivables 912.2m/397.7m, Revenue 7.84b/6.82b) |
| GMI: 0.97 (GM 42.31% / 43.73%) |
| AQI: 0.83 (AQ_t 0.52 / AQ_t-1 0.63) |
| SGI: 1.15 (Revenue 7.84b / 6.82b) |
| TATA: -0.03 (NI 519.4m - CFO 931.3m) / TA 15.3b) |
| Beneish M = -2.23 (Cap -4..+1) = BBB |
As of November 13, 2026, the stock is trading at USD 60.62 with a total of 2,762,438 shares traded. Over the past week, the price has changed by -10.68%, over one month by -2.85%, over three months by -5.41% and over the past year by -33.53%.
Current recommended Stop Loss: 57.00 (which is 6% or 1.2 ATR below the current price).
Somnigroup International has received a consensus analysts rating of 4.80. Therefore, it is recommended to buy SGI.
- StrongBuy: 8
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 87.4 | 44.2% |
P/E Trailing = 25.8354
P/E Forward = 22.4719
P/S = 1.8427
P/B = 3.2929
P/EG = 0.8336
Revenue TTM = 7.84b USD
EBIT TTM = 944.6m USD
EBITDA TTM = 1.21b USD
Long Term Debt = 5.28b USD (from longTermDebt, last quarter)
Short Term Debt = 557.0m USD (from shortTermDebt, last quarter)
Debt = 7.98b USD (corrected: LT Debt 5.28b + ST Debt 557.0m) + Leases 2.14b
Net Debt = 7.36b USD (calculated: Debt 7.98b - CCE 612.1m)
Enterprise Value = 21.8b USD (14.5b + Debt 7.98b - CCE 612.1m)
Interest Coverage Ratio = 3.90 (Ebit TTM 944.6m / Interest Expense TTM 242.5m)
EV/FCF = 31.23x (Enterprise Value 21.8b / FCF TTM 698.7m)
FCF Yield = 3.20% (FCF TTM 698.7m / Enterprise Value 21.8b)
FCF Margin = 8.91% (FCF TTM 698.7m / Revenue TTM 7.84b)
Net Margin = 6.62% (Net Income TTM 519.4m / Revenue TTM 7.84b)
Gross Margin = 43.73% ((Revenue TTM 7.84b - Cost of Revenue TTM 4.41b) / Revenue TTM)
Gross Margin QoQ = 42.02% (prev 44.81%)
Tobins Q-Ratio = 1.43 (Enterprise Value 21.8b / Total Assets 15.3b)
Interest Expense / Debt = 3.04% (Interest Expense 242.5m / Debt 7.98b)
Taxrate = 26.11% (183.3m / 702.1m)
NOPAT = 698.0m (EBIT 944.6m * (1 - 26.11%))
Current Ratio = 1.23 (Total Current Assets 3.03b / Total Current Liabilities 2.46b)
Debt / Equity = 1.72 (Debt 7.98b / totalStockholderEquity, last quarter 4.63b)
Debt / EBITDA = 6.06 (Net Debt 7.36b / EBITDA 1.21b)
Debt / FCF = 10.54 (Net Debt 7.36b / FCF TTM 698.7m)
Total Stockholder Equity = 3.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.90% (Net Income 519.4m / Total Assets 15.3b)
RoE = 14.72% (Net Income TTM 519.4m / Total Stockholder Equity 3.53b)
RoCE = 10.73% (EBIT 944.6m / Capital Employed (Equity 3.53b + L.T.Debt 5.28b))
RoIC = 5.38% (NOPAT 698.0m / Invested Capital 13.0b)
WACC = 6.53% (E(14.5b)/V(22.4b) * Re(8.89%) + D(7.98b)/V(22.4b) * Rd(3.04%) * (1-Tc(0.26)))
Discount Rate = 8.89% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.03 | Cagr: 9.92%
[DCF] Terminal Value 75.41% ; FCFF base≈699.3m ; Y1≈700.9m ; Y5≈739.6m
[DCF] Fair Price = 18.00 (EV 11.5b - Net Debt 7.36b = Equity 4.14b / Shares 230.2m; r=8.35% [WACC [floored]]; 5y FCF grow -0.23% → 2.50% )
EPS Correlation: 95.38 | EPS CAGR: 9.30% | SUE: -0.68 | # QB: 0
Revenue Correlation: 86.72 | Revenue CAGR: 23.21% | SUE: -0.04 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.67 | Chg30d=-8.24% | Revisions=-25% | Analysts=8
EPS current Year (2026-12-31): EPS=2.96 | Chg30d=-4.94% | Revisions=+25% | GrowthEPS=+9.6% | GrowthRev=+16.1%
EPS next Year (2027-12-31): EPS=3.60 | Chg30d=-8.42% | Revisions=-25% | GrowthEPS=+21.7% | GrowthRev=+29.8%
[Analyst] Revisions Ratio: -17% (up=1, down=2)